United Kingdom Archives

News and Trends 13 Apr 2015

Humabs and MedImmune partnership to develop an Influenza A treatment

Medimmune starts phase I clinical trial to investigate an antibody developed under a collaboration with Humabs BioMed for the treatment of influenza A. The novel antibody developed through Humabs’ Cellclone technology will be investigated a trial being conducted by MedImmune, the global biologics research and development arm of AstraZeneca. The investigational antibody, which has broad influenza-neutralizing […]

April 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 Apr 2015

Open Bionics, lending a 3D-Printed helping hand

Little could the young Joel Gibbard have ever imagined that those Meccano games he once used to play with as a child, would one day lead him to become Britain’s Design Engineer of the Year amongst other prestigious awards. Open Bionics, the Bristol-based company he founded, aims at providing low-cost robotic hands. I got to […]

April 7, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 3 Apr 2015

Back to Middle Age to re-discover some medicinal treatments

The long medieval period extends in the West over nearly a millennium and gradually enriched its knowledge in the medical field. Admired by the Greeks, Egyptian medicine made reference in Western medicine for millennia. Medical papyri mention over seven hundred healing substances, plant, animal, mineral, composing over a thousand remedies often associated with incantations to […]

April 3, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 20 Mar 2015

Optibrium introduces the lastest version of StarDrop

Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in the design of high quality compounds in drug discovery, agrochemicals and other chemistry fields. The latest release introduces the Matsy technology, based on matched molecular series analysis, which proposes strategies for chemical substitutions to optimise compound activity. Also included is […]

March 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 12 Mar 2015

Alderley Park Life Science Campus, on the go

Manchester Science Partnerships (MSP) and Bruntwood have revealed plans for the first phase of development at their flagship 162-hectare life science campus at Alderley Park, Cheshire. The plans centered on the Mereside science campus and were revealed at MIPIM – the annual international property conference held in Cannes, France. The session, titled ‘Translating Science into […]

March 12, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Mar 2015

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

Today, it has been accepted! The first drug approved through the Early Access to Medicine Scheme (EAMS), named pembrolizumab, is an immunotherapy treatment for advanced melanoma. The treatment has been developed by Merck, known as MSD outside the United States and Canada, with early development work carried out using MRC Technology’s antibody humanization expertise. EAMS is […]

March 11, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Mar 2015

Vitic database, the new must-have tool

The latest version of the Vitic Intermediates database, chemical database and information management system, has been released by Lhasa Limited, a leading global supplier of knowledge based software and associated databases. Initiated in 2006, Vitic Intermediates is a cross industry data sharing consortium created and co-ordinated by Lhasa Limited, through the Vitic Nexus platform, supported by […]

March 11, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 10 Mar 2015

350th anniversary of Philosophical Transactions, the first scientific journal

The world’s oldest continuously published journal, Philosophical Transactions of the Royal Society of London (RSL), celebrates its 350th anniversary on 6 March 2015. Academic journals are the cornerstone of science research. They serve as showcases, forums where researchers present their discoveries to the scientific community so they can be scrutinized, criticized and confirmed or rejected. […]

March 10, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 6 Mar 2015

Petunica circadia, where Art and Biotechnology meet

A changing-color flower that goes from blue to red and viceversa? It may sound like science fiction, but it’s purely biotechnology. A simple petunia to make a statement: gene engineering is not something to be afraid of. Biotechnology has so many applications that go from nourishing the increasing world population to growing beautiful flowers to […]

March 6, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 5 Mar 2015

Novartis announces completion of transactions with GSK

Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint venture, and sale of non-influenza Vaccines business Sharpens company focus on growing segments of innovative pharmaceuticals, eye care and generics Addition of GSK oncology products and two pipeline compounds is expected to expand Novartis position in targeted therapies and small […]

March 5, 2015 - 5 minutesmins - By Cédric Brock

News and Trends 5 Mar 2015

Synpromics and UniQure, new Collaboration in Gene Therapy.

Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene therapies to liver. Synpromics, a leading synthetic biology company, will use its unique approach to develop synthetic promoters with upregulated, liver cell specific, activity whilst also decreasing the promoter molecular […]

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 27 Feb 2015

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (RORγ). Inhibitors of this receptor are believed to have potential against a wide range of autoimmune diseases for which there is currently no safe, orally available and effective treatment. RORγ plays a key role in […]

February 27, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Humabs and MedImmune partnership to develop an Influenza A treatment

Open Bionics, lending a 3D-Printed helping hand

Back to Middle Age to re-discover some medicinal treatments

Optibrium introduces the lastest version of StarDrop

Alderley Park Life Science Campus, on the go

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

Vitic database, the new must-have tool

350th anniversary of Philosophical Transactions, the first scientific journal

Petunica circadia, where Art and Biotechnology meet

Novartis announces completion of transactions with GSK

Synpromics and UniQure, new Collaboration in Gene Therapy.

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!